Sure-Tech plans to invest between $1 million and $4 million in quality insurtech and fintech companies

The funds will enable the company to increase its backlog through business development and OEM agreements with automotive manufacturers and Tier1 suppliers

The company reported last night that some of its controlling shareholders sold off-stock transactions to the Phoenix insurance company and another institutional entity - the distribution was carried out at a premium of 2.7% on the market price at the time of execution.

Itamar Medical closed a $ 35 million offering with a relatively low discount; The company that is growing significantly intends to expand its marketing and sales efforts in the US.

The stock of the medical device company, which was listed on the US stock exchange in March 2019, has increased by 23%, and the last three months jumped by 70%. The Offering may increase the number of American investors share.

The Chairman of the Company, Ami Barlev: "The IPO will significantly support development activities" The offering was attended by Phoenix, More Investment House, Arkin Holdings, Klirmark Capital, Hachshara Insurance Company and Cybele Capital Markets which also led the transaction.

As reported, the company increases the private allocation and adds Itzik Taragan from Altshuler, Eran Fuchs who was senior at Excellence and other investors to Hagag and Horovitz

To date, 20 companies that are directly active in the Cannabis field are traded in Israel and their accumulated worth is about 2.3 billion NIS. The future is full of promises such as export form Israel approval and reforms in the local field. While this subject concerns us all, we found it just to present all the value chain of the Cannabis field with its players and markets.

The investor phase - Shachar Saidon, holder of Cybele Investment House

The medical equipment company, Itamar Medical completed yesterday a capital raise of 14.7 Million dollars as part of the company's registration to the American stock exchange. Among the Israeli investors: More Investment House, Mietav Dash Hazavim Investment Management and Noked's hedge funds. The CEO, Gilad Glick tells "Globes": "The belief in Israel is in achieving profitability as soon as possible, whereas the American market is interested in growth, the top line"
The American investors were Deerfield Management, Triple Gate Capital, West Elk Partners and Alpha Capital Anstalt (which is identified with Martin Schlaff and invests also in Collplant). Among the Israeli investors, More Investment House (that joined in the first part of the raise), Dash Hazavim Investment Management and Noked's hedge funds (that joined in the second part of the raise). The funds raising was led by Cybele Investment House who consults Itamar Medical in the local capital market.

The company raised 3.4 Million NIS; 80% of the orders quoted a higher price than the determined purchase price.
The issue was led by Rosario Capital, Cybele Capital Markets and Mr. Yuchi Korman who served as the issue consultant.

The raise was led by American investors, among them a fund managed by Deerfield Management, a large well known investment company that specializes in life sciences field. The raise was also led by the funds West Elk Partners, Triple Gate Capital and Alpha Capital Anstalt. The Israeli investor in this issue is More Investment House. Cybele consults Itamar Medical in the capital market including funds raising.

The decline of the Israeli hedge funds in the weakest year since 2008 crisis

Must Israeli hedge funds can only envy the foreign hedge fund DAFNA from Los Angeles that is marketed by Cybele Investment House. The fund is active since 1999 and closed 2018 with a positive yield of 7.99%. DAFNA is focused on Biomed and companies in the medical field.

British billionaire, Vincent Tchenguiz, who is known for his real-estate business, became a significant investor also in the local Biomed field. At an interview to "Globes" he explains how he plans to combine real-estate technologies with life technologies. Cybele Investment House manages Tchenguiz Group relations with the capital market

Pharmocann, one of the outstanding players in the cannabis field in Israel, is expected to record revenue of 14 million NIS and net profit of 3/2 million NIS

From the beginning of the year Pharmocann's revenue from selling medical cannabis is 14 million NIS. Equity increased from 2.5 million NIS to 7 million NIS. Medical's share soar already 40% last Wednesday

According to market evaluation the deal was done by assessment of two digit number million NIS company value. The CEO and owner of Ayalon Investments, Mr. Noam Braverman: "This step is part of a general strategy that includes expanding the investments activity to further domains together with professional partners in the field"

10.09.2015

The company is issuing a new series of bonds at 3.53% interest; at the institutional bid stage demands of 112 Million NIS were recorded

Institutional and private investors show trust at bond issuing led by Cybele Capital Markets and Rosario Capital

Cybele provides capital market consulting and escort services to Xenia and this year successfully led and completed public capital raising for the company.
Xenia holds 14% of Medi Tate that developed a product for treating prostate benign tumors

According the agreement United Therapeutics, one of the world's leading companies in the lung disease field will pay Collplant an advance of USD 5 million and USD15 million in millstone payments and also royalties. Collplant share is to be delisted from TASE by the end of the month and will continue to be traded on NASDAQ. Cybele Investment House provides capital market consulting and escort services to Collplant.

The funds raised are designated also for financing current activity and to continue promotion and activity development of Totalic. The issue was led by Cybele, Orion and Poalim IBI

The funds raised were designated for developing Escolle project in California which is part of a proven oil field. Cybele Capital Markets led the funds raising.

01.06.18
Shares and options issuing received a demand of 4.3 million NIS – nearly 46% over the offered amount. The tender closed above the minimum price

25.03.18
The company will allocate 22 million shares that make 7.7% of its issued capital by 0.95 NIS per share at a discount of 7% off the share price at 15 days prior to the funds raising.
The funds raising was led by Cybele Investment House.

25.03.2018
Itamar Medical has successfully completed raising nearly 22 million NIS by a private issue led by Cybele Investment House.
Among the participating bodies, Yelin Lapitot, Meitav Dash and Phoneix. The company is considering registration to NASDAQ

06.03.2018
Amir Efrati's Brosh Capital is entering the oil field; will search wells in the Dead Sea area and in Louisiana
The activist fund signed agreements to join the general partner that is managing Pertotex partnership, which up to date is hardly active and is traded on the preservation list of TASE at company value of 8 Million NIS.
The deal was led by Cybele Investment House

14.12.2017
Medical Compression Systems (MCS) is a public company skeleton. It's share price for the deal was fixed on 4.40 NIS that reflect 4.5% discount off the TASE price.
The holding of MCS that will shortly become a skeleton company, was sold today to the companies Cybele Investment House and Value Base according to a value of 8 Million NIS. Cybele Investment House, owned by Mr. Shachar Saidon and Mrs.Yael Schnitzer, purchased 16% and Value Base held by Mr. Victor Shamrich and Mr.Ido Neuberger, purchased 25%.

10.12.2017
Brainsway Ltd., marketed at TASE, raised nearly 30 Million NIS (8.5 Million USD) from Israeli institutional entities, among them Phoenix and IBI, that already holds nearly 8% of the company's shares. The funds raising was done according to a price of 15.5 NIS per share with a discount of 4.4% off market's price. The funds raise was led by Discount Capital Underwriting Ltd. And Cybele Capital Markets Ltd.
Brainsway Ltd., managed by Mr. Yaacov Michlin, developed and is marketing a treatment for Neurological and psychiatric illnesses using TMS (Transacranial Magnetic Stimulation) technology. The company is marketed according to a value of 245 Million NIS. Up to the third quarter of the year the company had 6 Million USD. In addition the company has an open credit line of 6 Million USD with Mizrahi bank.
In the coming few months the FDA's reply is expected for marketing the TMS helmet for treating OCD

07.11.2017
After successfully completing a full purchase offer, led by Cybele Capital Markets, Nitzan and Kidron will turn Nisko Electricity into a private company.
Nisko Electricity successfully exited from TASE. Izhak Nitzan and Arie Kidron delisted Nisko Electricity according to a valuation of 100M NIS for at a share price of 11.62, while most shares were held by the insurance companies Harel, Menora and Migdal.

13.06.2017
Epsilon investment house trust fund company invested in Cofix 5 million NIS and in return will receive shares and options for shares. Cofix general-manager, Mr. Haim Aharon: "We find importance in enhancing transparency and in having more institutional bodies involved in the company"

15.10.2017
On an overwhelming one on one with Mr. Vincent Tchenguiz, one of the sharpest financial brains in Britain, holding assets of billions BP, puts Israel highly on his investments map

07.09.2017
CBI sold holding of D-Pharm company for 300,000 NIS to Shachar Saidon's Cybele Investment House and to Victor Tshuva that may poor to it activity related to Real Estate, cyber and retail fields. D-Pharm share is rising

07.09.2017
The purchased pharmaceutical company lost nearly 57% of its value since the beginning of the year due to an experiment failure of its product for treating stroke

06.03.2017
The shares were purchased by Cybele Investments Company that is managed by Mr. Shsachar Saidon and is Mr. Vincent Tchenguiz representatives in Israel. Cybele Investments was also the underwriter of Xenia's share and option issuing last week that received demands that were three times bigger than the offered quantities and closed at a price that was 19% higher than the minimum price. This issuing raised for Xenia 5.3 million NIS.

Netex raises money at market price premium - Share prices spike